{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:16:17Z","timestamp":1778588177667,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18\\u202FK06796"],"award-info":[{"award-number":["18\\u202FK06796"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.vascn.2024.107518","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T12:30:06Z","timestamp":1716553806000},"page":"107518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of simultaneous determination of dopamine 2, histamine 1, and muscarinic acetylcholine receptor occupancies by antipsychotics using liquid chromatography with tandem mass spectrometry"],"prefix":"10.1016","volume":"127","author":[{"given":"Gaku","family":"Akashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimako","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.vascn.2024.107518_bb0005","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.lfs.2005.11.031","article-title":"Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer","volume":"78","author":"Barth","year":"2006","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/j.vascn.2024.107518_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.vascn.2024.107518_bb0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: A nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.vascn.2024.107518_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1988.01800250087012","article-title":"Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs","volume":"45","author":"Farde","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1016\/j.vascn.2024.107518_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.155.7.921","article-title":"5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation","volume":"155","author":"Kapur","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.vascn.2024.107518_bb0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jps.24691","article-title":"Cocktail-dosing microdialysis study to simultaneously assess delivery of multiple organic-cationic drugs to the brain","volume":"105","author":"Kitamura","year":"2016","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2024.107518_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(78)91047-8","article-title":"Regional distribution of muscarinic cholinergic receptors in rat brain","volume":"154","author":"Kobayashi","year":"1978","journal-title":"Brain Research"},{"issue":"Suppl. 2","key":"10.1016\/j.vascn.2024.107518_bb0040","first-page":"3","article-title":"Atypical antipsychotics: Sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.vascn.2024.107518_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archpsyc.60.2.198","article-title":"Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance","volume":"60","author":"Mulsant","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1016\/j.vascn.2024.107518_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","article-title":"Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients","volume":"33","author":"Nordstr\u00f6m","year":"1993","journal-title":"Biological Psychiatry"},{"issue":"19","key":"10.1016\/j.vascn.2024.107518_bb0055","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00213-015-4002-2","article-title":"Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: A positron emission tomography study in healthy volunteers","volume":"232","author":"Sato","year":"2015","journal-title":"Psychopharmacology"},{"issue":"9162","key":"10.1016\/j.vascn.2024.107518_bb0060","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(98)07549-7","article-title":"Schizophrenia","volume":"353","author":"Schuitz","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vascn.2024.107518_bb0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.vascn.2024.107518_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(82)90029-2","article-title":"High-affinity binding of [3H]doxepin to histamine H1-receptors in rat brain: Possible identification of a subclass of histamine H1-receptors","volume":"78","author":"Taylor","year":"1982","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2024.107518_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(92)90692-W","article-title":"In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons","volume":"213","author":"Varastet","year":"1992","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107518_bb0080","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1046\/j.1471-4159.1994.63030815.x","article-title":"m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC","volume":"63","author":"Wei","year":"1994","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.vascn.2024.107518_bb0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0006-8993(74)90738-0","article-title":"In vivo identification of muscarinic cholinergic receptor binding in rat brain","volume":"80","author":"Yamamura","year":"1974","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.vascn.2024.107518_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2006.06.008","article-title":"The physiological and pathophysiological roles of neuronal histamine: An insight from human positron emission tomography studies","volume":"113","author":"Yanai","year":"2007","journal-title":"Pharmacology and Therapeutics"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:49:08Z","timestamp":1778586548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871924000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":18,"alternative-id":["S1056871924000285"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107518","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of simultaneous determination of dopamine 2, histamine 1, and muscarinic acetylcholine receptor occupancies by antipsychotics using liquid chromatography with tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107518"}}